Orientations
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19: interim guidance, first issued 19 May 2022
Auteurs
Langues
- Anglais
Année de publication
2022
Type
Catégories
Maladies
Organisations
Mots-clés
